Table 3.4 Reported cases of laboratory-confirmed, chronic hepatitis B virus (HBV) infection, by sex, race/ethnicity, age group, and case criteria — Enhanced Viral Hepatitis Surveillance Sites, 2010

Print
Related Pages
Category
 CO
No. (%)		 CT
No. (%)		 MN
No. (%)		 NM
No. (%)		 NY
State
No. (%)		 NY
City
No. (%)		 OR
No. (%)		 San
Francisco
No. (%)		 Total
No. (%)
Sex
Female
 93
(52.0)		 160
(43.0)		 318
(48.3)		 24
(45.3)		 294
(38.2)		 3161
(43.4)		 154
(48.9)		 405
(45.9)		 4609
(38.5)
Male
 86
(48.0)		 212
(57.0)		 334
(50.8)		 29
(54.7)		 476
(61.8)		 4125
(56.6)		 159
(50.5)		 473
(53.6)		 5894
(49.3)
Missing
 0
(0.0)		 0
(0.0)		 6
(0.9)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 2
(0.6)		 4
(0.5)		 12
(0.1)
Race/Ethnicity*
AI / AN
 0
(0.0)		 0
(0.0)		 2
(0.3)		 2
(3.8)		 1
(0.1)		 2
(0.0)		 7
(2.2)		 0
(0.0)		 14
(0.1)
API
 88
(49.2)		 144
(38.7)		 229
(34.8)		 19
(35.9)		 253
(32.9)		 1447
(19.9)		 156
(49.5)		 507
(57.5)		 2843
(23.8)
Black
 29
(16.2)		 63
(16.9)		 165
(25.1)		 5
(9.4)		 127
(16.5)		 511
(7.0)		 16
(5.1)		 15
(1.7)		 931
(7.8)
White
 25
(14.0)		 73
(19.6)		 43
(6.5)		 12
(22.6)		 109
(14.2)		 142
(2.0)		 80
(25.4)		 25
(2.8)		 509
(4.3)
Hispanic
 8
(4.5)		 34
(9.1)		 4
(0.6)		 9
(17.0)		 31
(4.0)		 113
(1.6)		 10
(3.2)		 8
(0.9)		 217
(1.8)
Other
 2
(1.1)		 4
(1.1)		 6
(0.9)		 0
(0.0)		 12
(1.6)		 0
(0.0)		 5
(1.6)		 11
(1.3)		 40
(0.3)
Unknown / Missing
 27
(15.1)		 54
(14.5)		 209
(31.8)		 6
(11.3)		 237
(30.8)		 5071
(69.6)		 41
(13.0)		 316
(35.8)		 5961
(49.8)
Age group (yrs)
0-14
 13
(7.3)		 4
(1.1)		 24
(3.7)		 1
(1.9)		 20
(2.6)		 81
(1.1)		 13
(4.1)		 6
(0.7)		 162
(1.4)
15-24
 20
(11.2)		 28
(7.5)		 95
(14.4)		 4
(7.6)		 68
(8.8)		 689
(9.5)		 29
(9.2)		 24
(2.7)		 957
(8.0)
25-39
 80
(44.7)		 137
(36.8)		 291
(44.2)		 13
(24.5)		 241
(31.3)		 3134
(43.0)		 102
(32.4)		 259
(29.4)		 4257
(35.6)
40-54
 32
(17.9)		 128
(34.4)		 165
(25.1)		 25
(47.2)		 256
(33.3)		 2200
(30.2)		 108
(34.3)		 299
(33.9)		 3213
(26.9)
55+
 34
(19.0)		 75
(20.2)		 83
(12.6)		 10
(18.9)		 185
(24.0)		 1182
(16.2)		 63
(20.0)		 294
(33.3)		 1926
(16.1)
Missing
 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)		 0
(0.0)
Place of Birth
United States
 23
(12.9)		 32
(8.6)		 24
(3.7)		 U
(U)		 53
(6.9)		 12
(0.2)		 60
(19.1)		 26
(3.0)		 230
(1.9)
Outside US
 103
(57.5)		 159
(42.7)		 418
(63.5)		 U
(U)		 194
(25.2)		 197
(2.7)		 149
(47.3)		 140
(15.9)		 1360
(11.4)
Missing/
Unknown
 53
(29.6)		 181
(48.7)		 216
(32.8)		 U
(U)		 523
(67.9)		 7077
(97.1)		 106
(33.7)		 716
(81.2)		 8872
(74.2)
Case criteria†
Hepatitis B surface antigen
 176
(98.3)		 372
(100.0)		 644
(97.9)		 U
(U)		 740
(96.1)		 6939
(95.2)		 273
(86.7)		 835
(94.7)		 9979
(83.4)
Hepatitis B e-antigen
 36
(20.1)		 48
(12.9)		 129
(19.6)		 U
(U)		 161
(20.9)		 1449
(19.9)		 26
(8.3)		 101
(11.5)		 1950
(16.3)
HBV-DNA
 51
(28.5)		 148
(39.8)		 397
(60.3)		 U
(U)		 464
(60.3)		 5564
(76.4)		 36
(11.4)		 544
(61.7)		 7204
(60.2)
Total new
reported cases
 179 372 658 53 770 7,286 315 882 10,515
Estimated 2010
population
 5,029,196 3,574,097 5,303,925 2,059,179 11,202,969 8,175,133 3,831,074 805,235 39,980,808
Rate per 100,000 population
 3.6 10.4 12.4 2.6 6.9 89.1 8.2 109.5 26.3

*Categorized in the following order: 1) Hispanic; 2) AI/AN; 3) API; 4) Black; 5) White; 6) Other;
† Cases can be reported with more than one laboratory test result
U=No data available for reporting